默克公司提出逾30亿美元收购MoonLake Immunotherapeutics，正值行业变革之际-动脉橙

默克公司提出逾30亿美元收购MoonLake Immunotherapeutics，正值行业变革之际

2025-06-03 GeneOnline 等7家媒体报道收购





默克公司已提出超过30亿美元收购处于后期药物开发阶段的生物技术公司MoonLake Immunotherapeutics，显示出对该领域的重新关注。其他行业动态包括Arrowhead Pharmaceuticals的肥胖症治疗试验、ASCO上关于癌症疗法的讨论，以及FDA探索使用人工智能优化审评流程。这些进展突显了制药和医疗保健行业在面对科学和运营挑战时的创新与适应能力。（摘要由动脉网AI生成）

关联公司

 默克中国

2025-06-03 Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Shifts

GeneOnline
2025-06-04 Merck in Talks to Acquire MoonLake Immunotherapeutics for $3 Billion

GeneOnline
2025-06-06 Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Focus on Inflammatory Disease Treatments

GeneOnline
2025-06-14 Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Developments

GeneOnline
2025-06-16 Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Developments

GeneOnline
2025-06-18 Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Challenges

GeneOnline
2025-06-19 Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Sector Challenges

GeneOnline